LONDON, UK: Tate & Lyle PLC, a leading global provider of food and beverage ingredients and solutions, announces that it has today completed the acquisition of Quantum Hi-Tech (Guangdong) Biological Co., Ltd (Quantum), a leading prebiotic dietary fibre business located in China. The signing of a conditional agreement for this acquisition was announced on 31 March 2022.
Nick Hampton, Chief Executive of Tate & Lyle, said: “This acquisition significantly strengthens our fortification platform and our position as a leading global player in dietary fibres, while extending our presence in China and Asia. FOS and GOS fibres are highly complementary to our existing fibre portfolio and will allow us to offer a broader range of solutions to our customers across key markets.
We are delighted to welcome our new colleagues from Quantum to Tate & Lyle. Quantum is a great fit with our growth strategy and our purpose of Transforming Lives through the Science of Food, giving us more opportunities to improve gut health and provide fibre fortification for consumers across the world.”
Tate & Lyle is a leading global provider of food and beverage ingredients and solutions. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.
Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year ended 31 March 2021, Tate & Lyle’s revenue from continuing operations totaled £1.2 billion.